Theoria Science|Leading the way to health with cutting-edge exosome research

2021.11.17 Takahiro Ochiya was selected for a Clarivate Highly Cited Researcher - 2021 by Clarivate Analytics. For details please click here.

2021.08.02 Theoria Science successfully raises 5 million dollars in Series A round. Click here for details.

2020.11.19 Takahiro Ochiya was selected for a Clarivate Highly Cited Researcher - 2020 by Clarivate Analytics. For details please click here.

2020.03.11 Theoria Science covered in a special feature article on Nikkei Biotech ONLINE. Click here to the article.

2020.03.04 Theoria's service featured in an article on the liquid biopsy market on Nikkei Biotech ONLINE. Click here to the article.

2019.12.17 Yutaro Kasai appointed as part-time auditor.

2019.11.08 Patents registered related to a drug delivery system for passing through the blood-brain barrier and the diagnosis, prevention, and treatment of cancer brain metastases.

2019.09.06 Capital increase announced with Angel Bridge as the underwriter.

2019.07.18 Akihiko Asami appointed as external director

2018.08.17 Patent registered related to a method of detection for colorectal cancer.

  • 1
  • 2